Effect of Bright Light Treatment On Elders In a Long Term Care Environment
BrightLights
1 other identifier
interventional
32
1 country
1
Brief Summary
The investigators hypothesize that significant exposure to artificial morning bright light (approximately 200 lux of primarily blue light at eye level for thirty minutes daily) as compared to sham bright red light (placebo) will:
- 1.improve sleep quality
- 2.improve cognitive scores
- 3.improve depression scores
- 4.improve quality of life scores.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2010
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 4, 2010
CompletedFirst Posted
Study publicly available on registry
January 5, 2010
CompletedStudy Start
First participant enrolled
March 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedAugust 11, 2010
March 1, 2010
3 months
January 4, 2010
August 10, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
assessment of cognitive functioning using MicroCog
once prior to intervention, once near the end of intervention, once four weeks after intervention
Assessment of mood using the Geriatric Depression Scale
once prior to intervention, once near the end of intervention, once four weeks after intervention
assessment of quality of life using the SF-36
once prior to intervention, once near the end of intervention, once four weeks after intervention
assessment of sleep quality using the Pittsburgh Sleep Quality Index
once prior to intervention, once near the end of intervention, once four weeks after intervention
assessment of mood using the Profile of Moods Survey
weekly throughout the duration of the study
assessment of sleep quality using the Epworth Sleepiness Scale
weekly throughout the duration of the study
day and nightime activity level (5 subjects per group only) using Actigraphy
two weeks prior to light exposure and the second two weeks during light exposure (continuous measurements)
Secondary Outcomes (2)
salivary melatonin levels
once prior and near the end of light exposure period
salivary cortisol levels
once prior and near the end of light exposure period
Study Arms (2)
bright light
ACTIVE COMPARATORBright light has been shown to entrain circadian rhythm so our treatment arm will use thirty minutes of early morning exposure to bright blue light for a four week period.
red light
SHAM COMPARATORLow level red light is a weak entrainment stimulus of circadian rhythm. Elders in the control group will be exposed to low level red light as a placebo for thirty minutes daily for four weeks.
Interventions
Elders will be engaged in an activity period which will focus their attention in the direction of bright light, thus ensuring viewing the light source for a daily exposure of thirty minutes.
Low level red light should not entrain circadian rhythm and will serve as a placebo control
Eligibility Criteria
You may qualify if:
- residents in Masonic Villages, Elizabethtown, PA long term care
- ability to give informed consent and complete the neuropsychological tests
You may not qualify if:
- blindness
- severe illness expected to preclude the ability to complete treatment
- moderate to severe dementia that precludes the ability to complete testing
- light sensitivity making treatment to light therapy uncomfortable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Masonic Villages
Elizabethtown, Pennsylvania, 17022, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Noel H Ballentine, MD
Milton S. Hershey Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 4, 2010
First Posted
January 5, 2010
Study Start
March 1, 2010
Primary Completion
June 1, 2010
Study Completion
June 1, 2010
Last Updated
August 11, 2010
Record last verified: 2010-03